메뉴 건너뛰기




Volumn 39, Issue , 2016, Pages 220.e1-220.e7

Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease

(39)  Barber, Imelda S a   García Cárdenas, Jennyfer M a   Sakdapanichkul, Chidchanok a   Deacon, Christopher a   Zapata Erazo, Gabriela a   Guerreiro, Rita b   Bras, Jose b   Hernandez, Dena c   Singleton, Andrew c   Guetta Baranes, Tamar a   Braae, Anne a   Clement, Naomi a   Patel, Tulsi a   Brookes, Keeley a   Medway, Christopher a,j   Chappell, Sally a   Mann, David M d   Morgan, Kevin a   Passmore, Peter e   Craig, David e   more..


Author keywords

Alzheimer's disease; APP; Early onset; Rs367709245; Screening; Sporadic

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COMPLEMENTARY DNA;

EID: 84959506686     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.12.011     Document Type: Article
Times cited : (12)

References (17)
  • 2
    • 84910005783 scopus 로고    scopus 로고
    • 2014 Alzheimer's disease facts and figures
    • Alzheimer's Association
    • 2014 Alzheimer's disease facts and figures. Alzheimers Dement. 2014, 10:e47-e92. Alzheimer's Association.
    • (2014) Alzheimers Dement. , vol.10 , pp. e47-e92
  • 4
    • 84865176138 scopus 로고    scopus 로고
    • Locus-specific mutation databases for neurodegenerative brain diseases
    • Cruts M., Theuns J., Van Broeckhoven C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum. Mutat. 2012, 33:1340-1344.
    • (2012) Hum. Mutat. , vol.33 , pp. 1340-1344
    • Cruts, M.1    Theuns, J.2    Van Broeckhoven, C.3
  • 6
    • 84893027063 scopus 로고    scopus 로고
    • Pattern of variation influencing antipychotic treatment outcomes in South African first-episode schizophrenia patients
    • Drogemoller B., Niehause D., Chiliza B., Merwe L., Asmal L., Malhotra A., Emsley R., Warnich L. Pattern of variation influencing antipychotic treatment outcomes in South African first-episode schizophrenia patients. Pharmacogenomics 2014, 15:189-199.
    • (2014) Pharmacogenomics , vol.15 , pp. 189-199
    • Drogemoller, B.1    Niehause, D.2    Chiliza, B.3    Merwe, L.4    Asmal, L.5    Malhotra, A.6    Emsley, R.7    Warnich, L.8
  • 11
    • 48249148310 scopus 로고    scopus 로고
    • Tau exon 10 alternative splicing and tauopathies
    • Liu F., Gong C.X. Tau exon 10 alternative splicing and tauopathies. Mol. Neurodegener. 2008, 3:8.
    • (2008) Mol. Neurodegener. , vol.3 , pp. 8
    • Liu, F.1    Gong, C.X.2
  • 17
    • 3042852095 scopus 로고    scopus 로고
    • A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10
    • Yu Q., Guo J., Zhou J. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10. J. Neurochem. 2004, 90:164-172.
    • (2004) J. Neurochem. , vol.90 , pp. 164-172
    • Yu, Q.1    Guo, J.2    Zhou, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.